Finally, high cerebrospinal fluid (CSF) CXCL12 levels are detected in patients with increased grey matter lesion number and volume, which shows that CXCL12 could be used as a marker of MS progression [18]. This evidence concerns the gene CXCL12 and myeloid sarcoma.